🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

C. López-Pedrera

Instituto Maimónides de Investigación Biomédica de Córdoba

ORCID: 0000-0003-2067-4603
MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.487Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lara D. Veeken(2024)10.1093/rheumatology/keae583
Top 39%
0.487DataRank
Top 39%8 citations

Massimo Radin, Silvia Grazietta Foddai, Alice Barinotti, Danieli Andrade, Maria G. Tektonidou +23 more

Papers

Driven by 4 papers — median percentile 61. Top paper: “ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)”.

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Lara D. Veeken(2024)10.1093/rheumatology/keae583
Top 39%
0.487DataRank
Top 39%8 citations

Massimo Radin, Silvia Grazietta Foddai, Alice Barinotti, Danieli Andrade, Maria G. Tektonidou +23 more

Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository

The Journal of Rheumatology(2020)10.3899/jrheum.200513
N/A
0.477DataRank · unranked
23 citations

Ecem Sevim, Jackie Finik, Danieli Andrade, Vittorio Pengo, Savino Sciascia +23 more

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Laboratory Investigation(2023)10.1016/j.labinv.2023.100147
N/A
0.312DataRank · unranked
7 citations

Rohan Willis, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza +67 more

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Lara D. Veeken(2023)10.1093/rheumatology/kead292
N/A
0DataRank · unranked
18 citations

Yasaman Ahmadzadeh, Maria G. Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte +64 more